Renal oncocytoma other diagnostic studies

Revision as of 13:54, 10 May 2019 by Homa Najafi (talk | contribs)
Jump to navigation Jump to search

Renal oncocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal oncocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal oncocytoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal oncocytoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal oncocytoma other diagnostic studies

CDC on Renal oncocytoma other diagnostic studies

Renal oncocytoma other diagnostic studies in the news

Blogs on Renal oncocytoma other diagnostic studies

Directions to Hospitals Treating Renal oncocytoma

Risk calculators and risk factors for Renal oncocytoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

There are no other diagnostic study findings associated with renal oncocytoma.

Other Diagnostic Studies

There are no other diagnostic study findings associated with renal oncocytoma.

Overview

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include:

  • [Finding 1]
  • [Finding 2]
  • [Finding 3]

OR

Other diagnostic studies for [disease name] include:

  • [Diagnostic study 1], which demonstrates:
    • [Finding 1]
    • [Finding 2]
    • [Finding 3]
  • [Diagnostic study 2], which demonstrates:
    • [Finding 1]
    • [Finding 2]
    • [Finding 3]

Equivocal results from multiple studies investigating the use of percutaneous renal biopsy have resulted in its limited role in the diagnosis of solid renal masses. A recent small retrospective series from MD Anderson Cancer Center examined fine needle aspiration cytology of eosinophilic renal neoplasms with special stains (eg, cytokeratin, vimentin, and Hale’s colloidal iron) and electron microscopy (in selected cases), demonstrating some success in predicting final pathology [18]. However, the value of this study was limited because of its retrospective nature and the lack of surgical specimens to provide “gold standard” data from a significant number of patients felt to have oncocytoma. Frozen-section needle biopsy performed at time of renal exploration failed to yield reliable diagnoses in a recent prospective study from our institution [41]. One hundred three patients underwent radical or partial nephrectomy for their renal tumors. After resection, a “back table” biopsy was obtained from each tumor using an 18-gauge biopsy gun and sent for frozen section. Two urologic pathologists independently reviewed the specimens, and the results were compared with those from whole-mount permanent sections. Overall accuracy of the two pathologists was 76% and 80%, respectively, with nondiagnostic rates of 11% and 17%. Both pathologists diagnosed 5% of the malignant lesions as benign, and 21% and 36% of benign lesions as malignant. The quality of the biopsies themselves was clearly ideal and not subject to the vagaries inherent in percutaneous biopsies. Needle biopsy of the tumor can be a useful strategy to diagnose oncocytoma in the very elderly or very sick patient with a renal tumor. There have been cases reported in which patients with large bilateral and unresectable renal oncocytomas have been observed for many years without showing distinct tumoral progression. Such observational treatment may be entirely appropriate for patients at poor operative risk because of extensive comorbidities

References

Template:WH Template:WS